US EditionTrump demands pharma companies slash drug prices in next 60 days
UNITED STATES, JUL 31 – President Trump set a 60-day deadline for 17 drugmakers to lower U.S. prices to match those in other developed nations, aiming to reduce costs up to 60%, White House said.
- President Donald Trump has demanded that 17 pharmaceutical firms lower drug prices for Americans within 60 days or face government action, citing prices that can be up to three times higher than in other developed countries.
- Trump's directive includes extending 'Most Favored Nation' pricing to Medicaid and new drugs, urging companies to comply while warning that failure to do so could lead to the use of 'every tool in our arsenal'.
- Trump's approach is driven by public demand for lower prices and aims to eliminate the disparity between U.S. drug costs and those in other nations.
- UK officials have expressed concern about the potential impact on the NHS due to Trump's actions on drug pricing.
140 Articles
140 Articles
The US President has sent a letter in the form of an ultimatum to the 17 largest companies in the sector, including French Sanofi, to reduce their prices within 60 days. The White House is encouraging them to raise their prices outside the United States, particularly in Europe.
Fact Sheet: President Donald J. Trump Announces Actions to Get Americans the Best Prices in the World for Prescription Drugs
FOR IMMEDIATE RELEASE 07/31/25 Fact Sheet: President Donald J. Trump Announces Actions to Get Americans the Best Prices in the World for Prescription Drugs REDUCING DRUG PRICES FOR AMERICANS AND TAXPAYERS: Today, President Donald J. Trump sent letters to leading pharmaceutical manufacturers outlining the steps they must take to bring down the prices of prescription drugs in the United States to match the lowest price offered in other developed…
Within 60 days, Novo Nordisk and a number of other international pharmaceutical companies must lower the prices of medicines in the United States. Donald Trump demands it, but the American healthcare system is not simple.
U.S. President Donald Trump increased pressure on major pharmaceutical companies to match their prices in the U.S. with the much lower ones offered to patients in other countries, although U.S. experts are...
Coverage Details
Bias Distribution
- 48% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
